atazanavir sulfate has been researched along with etravirine in 4 studies
Studies (atazanavir sulfate) | Trials (atazanavir sulfate) | Recent Studies (post-2010) (atazanavir sulfate) | Studies (etravirine) | Trials (etravirine) | Recent Studies (post-2010) (etravirine) |
---|---|---|---|---|---|
1,102 | 246 | 590 | 572 | 90 | 321 |
Protein | Taxonomy | atazanavir sulfate (IC50) | etravirine (IC50) |
---|---|---|---|
Chain A, Reverse transcriptase/ribonuclease H | HIV-1 M:B_HXB2R | 0.0021 | |
Chain B, p51 RT | HIV-1 M:B_HXB2R | 0.0021 | |
Chain A, Reverse transcriptase/ribonuclease H | HIV-1 M:B_HXB2R | 0.0021 | |
Chain B, p51 RT | HIV-1 M:B_HXB2R | 0.0021 | |
ATP-binding cassette sub-family C member 3 | Homo sapiens (human) | 5.1 | |
Cytochrome P450 1A2 | Homo sapiens (human) | 0.025 | |
ATP-dependent translocase ABCB1 | Homo sapiens (human) | 7.6 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.019 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 0.032 | |
Cytochrome P450 2C9 | Homo sapiens (human) | 0.017 | |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE) | 0.37 | |
Cruzipain | Trypanosoma cruzi | 4 | |
Multidrug resistance-associated protein 1 | Homo sapiens (human) | 8.5 | |
Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 0.01 | |
Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.097 | |
Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 0.01 | |
Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 0.01 | |
Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 0.01 | |
Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 0.01 | |
Reverse transcriptase/RNaseH | Human immunodeficiency virus 1 | 0.2711 | |
Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 0.01 | |
Canalicular multispecific organic anion transporter 1 | Homo sapiens (human) | 7.8 | |
Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 0.01 | |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 6 | |
Reverse transcriptase | Human immunodeficiency virus 1 | 0.0186 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Feinberg, J | 1 |
Buclin, T; Bugnon, O; Cavassini, M; Csajka, C; Fuchs, A; Rotzinger, A; Schneider, MP | 1 |
Centeno-Tablante, E; Cotton, MF; Frigati, L; Lazarus, E; Nicol, L; Nicol, S; Penazzato, M; Violari, A | 1 |
Bonora, S; Calcagno, A; De Benedetto, I; Guastamacchia, G; Trunfio, M | 1 |
2 review(s) available for atazanavir sulfate and etravirine
Article | Year |
---|---|
Second- and Third-line Antiretroviral Therapy for Children and Adolescents: A Scoping Review.
Topics: Adolescent; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Child; Child, Preschool; Clinical Trials, Phase II as Topic; Cohort Studies; Darunavir; Drug Administration Schedule; Female; HIV Infections; Humans; Male; Nitriles; Practice Guidelines as Topic; Pyridazines; Pyrimidines; Raltegravir Potassium; Viral Load | 2017 |
A review of the potential mechanisms of neuronal toxicity associated with antiretroviral drugs.
Topics: Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Astrocytes; Atazanavir Sulfate; Benzoxazines; Central Nervous System; Cognitive Dysfunction; Cyclopropanes; Dideoxynucleosides; Endothelial Cells; HIV Infections; Humans; Neurons; Nevirapine; Nitriles; Oligodendroglia; Pyrimidines | 2020 |
2 other study(ies) available for atazanavir sulfate and etravirine
Article | Year |
---|---|
Promising new agents on the horizon.
Topics: Adenine; Anti-HIV Agents; Atazanavir Sulfate; CD4 Lymphocyte Count; Clinical Trials as Topic; HIV Infections; HIV Protease Inhibitors; Humans; Nitriles; Oligopeptides; Organophosphonates; Organophosphorus Compounds; Pyridazines; Pyridines; Pyrimidines; Reverse Transcriptase Inhibitors; Tenofovir; Viral Load | 2002 |
Comparison of Population Pharmacokinetics Based on Steady-State Assumption Versus Electronically Monitored Adherence to Lopinavir, Atazanavir, Efavirenz, and Etravirine: A Retrospective Study.
Topics: Alkynes; Atazanavir Sulfate; Benzoxazines; Cyclopropanes; Drug Monitoring; HIV Infections; HIV Protease Inhibitors; Humans; Lopinavir; Medication Adherence; Nitriles; Pyridazines; Pyrimidines; Retrospective Studies; Reverse Transcriptase Inhibitors | 2016 |